Ghaderi Nasab Zahra, Sharifi Hamid, Mangolian Shahrbabaki Parvin
MSc Student, Department of Biostatistics and Epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran.
HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Front Public Health. 2024 Nov 19;12:1372698. doi: 10.3389/fpubh.2024.1372698. eCollection 2024.
Hypertension has been identified as the most important risk factor for disability and premature death worldwide. This study aimed to explain the factors that facilitate medication adherence from the perspective of patients with hypertension in southeastern Iran. This qualitative study used conventional content analysis and purposive sampling methods to achieve data saturation, involving 25 participants. Facilitating factors were categorized into two main categories: individual and family factors and organizational support. Individual factors included motivational fears, disease acceptance, healthy lifestyle, disease monitoring, and follow-up. Family factors included family support, while organizational support included governmental support to provide inexpensive medicines, comprehensive healthcare team support, health insurance access, and media training. These factors were identified as essential facilitators that significantly influence appropriate adherence to hypertensive drugs. This study revealed that various factors affected medication adherence in these patients, and efforts should be made to improve hypertension treatment and increase medication adherence. Measures taken to control hypertension are cost-effective to reduce the burden associated with this disease. The findings of this study can be valuable in formulating policies for the treatment and care of hypertension.
高血压已被确认为全球残疾和过早死亡的最重要风险因素。本研究旨在从伊朗东南部高血压患者的角度解释促进药物依从性的因素。这项定性研究采用传统内容分析法和目的抽样法以达到数据饱和，共涉及25名参与者。促进因素分为两大类：个人和家庭因素以及组织支持。个人因素包括动机性恐惧、疾病接受度、健康生活方式、疾病监测和随访。家庭因素包括家庭支持，而组织支持包括政府提供廉价药品的支持、综合医疗团队支持、医疗保险覆盖、以及媒体培训。这些因素被确定为显著影响高血压药物合理依从性的重要促进因素。本研究表明，多种因素影响了这些患者的药物依从性，应努力改善高血压治疗并提高药物依从性。为控制高血压所采取的措施在减轻该疾病相关负担方面具有成本效益。本研究结果对于制定高血压治疗和护理政策可能具有重要价值。
